Herlene Budol on pageantry
HERLENE BUDOL – The Kapuso actress and beauty queen recently shared that she will rest from pageantry for now.
On Tuesday, March 5, 2024, Herlene Budol has signed a management contract with Sparkle GMA Artist Center, the talent management arm of GMA Network.
Present at the contract signing are Sparkle Vice President Joy Marcelo, Sparkle Senior Talent Manager Jan Navarro, GMA Network’s Senior Vice President Atty. Annette Gozon-Valdes, and Herlene’s mentor Wilbert Tolentino.
According to a report on GMA News Online, Herlene was asked in an interview on the sidelines of her contract signing on Tuesday if she’s still open to joining beauty pageants. In response, she said that she’ll be resting in the pageantry world for now, as she needs to focus on her acting career.
Although the beauty queen said she’s not closing her doors in the pageantry, the actress said that she will focus on what’s currently on her plate at the moment.
“Siguro ngayon, pahinga muna. Parang mas kailangan ko munang mag-focus sa pag-acting kasi parang di kaya ng braincells ko kapag sabay-sabay sila. So kailangan isa-isa lang muna,” Herlene said. “At ‘saka masaya ako ngayon sa ginagawa ko. Hindi ko naman kino-close na hindi na ako sasali. I mean, papahinga lang. Siguro, mag-focus ako sa kung anong nandiyan muna.”
You may also visit – Herlene Budol On Negative Comments About Her
The actress previously starred in Kapuso series “Magandang Dilag”, which marked her first lead role in a series. She currently stars in the Kapuso action-packed series “Black Rider” and the second season of Kapuso action-comedy series “Walang Matigas na Pulis sa Matinik na Misis”.
Herlene has also appeared in various Kapuso programs such as Magpakailanman, Madrasta, Stories From The Heart: Never Say Goodbye, Daddy’s Gurl, and False Positive.
She also made a name for herself in pageantry before showbiz, as she was crowned Miss Philippines Tourism at the Miss Grand International pageant in July and she was also named first runner-up in Binibining Pilipinas 2022.